Advisor

Nathan Spreng

Advisor

Nathan Spreng advises EyeThree on clinical research and the application of brain imaging to Alzheimer’s disease and cognitive decline.

He is a leading collaborator on the PREVENT-AD study, one of the largest efforts to predict cognitive decline.